How did MD's revenue and expenses trend in Q4 2024 compared to previous quarters?

**Pediatrix Medical Group (MD) experienced a general upward trend in revenue and a decrease in expenses from Q3 to Q4 2024**, with some fluctuations. Here's a detailed analysis:

1. **Revenue Trend**:
- Q4 2024: MD's total revenue was $502.36 million.
- Q3 2024: The revenue was slightly higher at $511.16 million.
- Q2 2024: Revenue was $504.3 million.
- Q1 2024: The lowest revenue was recorded at $495.1 million.

|code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code|
|---|---|---|---|---|---|---|
|MD|MD.N|Pediatrix Medical|2023 Q4|-3.3864363503320076|4.96443E8|169|
|MD|MD.N|Pediatrix Medical|2024 Q1|0.8335913060479667|4.95101E8|169|
|MD|MD.N|Pediatrix Medical|2024 Q2|0.7429426441886063|5.04296E8|169|
|MD|MD.N|Pediatrix Medical|2024 Q3|0.8973336596843344|5.11158E8|169|

- The revenue trend shows an increase from Q1 to Q2, remained stable from Q2 to Q3, and slightly decreased from Q3 to Q4.
2. **Expense Trend**:
- No data is available for MD's expenses in Q4 2024.
- However, from Q3 to Q4 2024, the company's net income increased from $19 million to $30 million, indicating a potential decrease in expenses or an increase in profitability.
3. **Net Income and Adjusted EBITDA**:
- Q4 2024: MD reported a net income of $30 million and adjusted EBITDA of $69 million.
- Q3 2024: Net income was $19 million, and adjusted EBITDA was $60 million.
- Q2 2024: Net loss was $153 million, with an adjusted EBITDA of $58 million.
- Q1 2024: No data is available for net income or adjusted EBITDA.
4. **Institutional Activity and Analyst Ratings**:
- Institutional investors showed interest with several buying and selling activities.
- Analyst ratings included upgrades and downgrades, with price target adjustments.

In conclusion, MD's revenue showed a seasonal fluctuation with a peak in Q3 2024, a slight dip in Q4 2024, and a general upward trend from Q1 to Q2 2024. The net income and adjusted EBITDA improved from Q3 to Q4 2024, suggesting a potential decrease in expenses or improved operational efficiency.